Cancer Molecular Therapeutics
- Institution
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA
- Principal investigator
- Michael Jackson
- Funding
- $255K
- Duration
- 1997–2027
Moonbase score
Still being scored
Abstract
The overall goals of the Cancer Molecular Therapeutics (CMT) Program (formerly Aging, Cancer and Immuno-oncology (ACI)) are to engage active collaborations among members of the program to enable new research initiatives and grant programs that will define how the interplay among cancer cells, immune cells, stromal components, and vasculature regulates the growth and metastasis of solid and hematologic malignancies, and to use this knowledge to discover new, more effective cancer treatments.
LOADING MOONBASE SCORE
Questions for SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Sanford Burnham Prebys Medical Discovery InstituteNot yet scored
Discovery and optimization of ApoE4 correctors for the treatment of Alzheimer's Disease
Michael Jackson · $878K · 2024–2029
- NIH · Sanford Burnham Prebys Medical Discovery InstituteNot yet scored
Brain-penetrant GPR88 agonists as novel therapeutics for opioid abuse
Michael Jackson · $644K · 2022–2027
- NIH · Sanford Burnham Prebys Medical Discovery InstituteNot yet scored
Identification of microproteins associated with hematopoiesis and related diseases
Aniruddha J. Deshpande · $293K · 2025–2027